Related Experiment Video
Updated: May 15, 2026
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
[Type 2 diabetes mellitus-screening and prevention].
Marietta Stadler1, Rudolf Prager
13. Medizinische Abteilung, Krankenhaus der Stadt Wien-Hietzing, Wien, Österreich.
Wiener Klinische Wochenschrift
|December 20, 2012
Summary
Type 2 diabetes is rising globally, with many cases undiagnosed. This article outlines Austrian guidelines for effective screening and prevention strategies to combat the growing diabetes epidemic.
Area of Science:
- Endocrinology
- Public Health
- Preventive Medicine
Context:
- Increasing prevalence of diabetes mellitus in industrialized nations.
- Significant proportion of diabetes cases remain undiagnosed, hindering timely intervention.
- Growing need for evidence-based guidelines to address the diabetes epidemic.
Purpose:
- To present the Austrian Diabetes Association's recommendations for type 2 diabetes screening.
- To provide evidence-based strategies for the prevention of type 2 diabetes.
- To guide healthcare professionals in managing and reducing the burden of diabetes.
Summary:
- The guidelines focus on identifying at-risk individuals through targeted screening protocols.
- Recommendations emphasize lifestyle modifications and early interventions to prevent diabetes onset.
- The document synthesizes current scientific evidence to support its recommendations.
Impact:
- Aims to improve early detection rates of type 2 diabetes.
- Expected to reduce the incidence of diabetes and its associated complications.
- Contributes to public health efforts in managing the diabetes epidemic in westernized countries.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...